日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structural insights into σ28-dependent transcription initiation and its regulation by anti-sigma factor in Pseudomonas aeruginosa

铜绿假单胞菌中σ28依赖性转录起始及其抗σ因子调控的结构解析

Sheenu; Kumar, Vineet; Sahoo, Pankaj Kumar; Kandiah, Eaazhisai; Jain, Deepti

Real-World Data Quality Framework for Oncology Time to Treatment Discontinuation Use Case: Implementation and Evaluation Study

肿瘤治疗停止时间用例的真实世界数据质量框架:实施和评估研究

Ru, Boshu; Sillah, Arthur; Desai, Kaushal; Chandwani, Sheenu; Yao, Lixia; Kothari, Smita

Raising the Bar for Real-World Data in Oncology: Approaches to Quality Across Multiple Dimensions

提升肿瘤学真实世界数据的标准:多维度质量提升方法

Castellanos, Emily H; Wittmershaus, Brett K; Chandwani, Sheenu

Women's Experiences Following Peripartum Hysterectomy: A Qualitative Study

产后子宫切除术后女性的经历:一项定性研究

Gahlawat, Sheenu; Dutta, Monika; Varatharajaperumal, Venkadalakshmi; Saha, Pradip Kumar

REC domain stabilizes the active heptamer of σ54-dependent transcription factor, FleR from Pseudomonas aeruginosa

REC结构域稳定铜绿假单胞菌σ54依赖性转录因子FleR的活性七聚体

Pankaj Kumar Sahoo ,Sheenu ,Deepti Jain

Antimicrobial potential of Indian Cinnamomum species

印度肉桂属植物的抗菌潜力

Singh, Bharat; Nathawat, Sheenu; Avtar Sharma, Ram

Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany

德国晚期黑色素瘤患者使用帕博利珠单抗进行真实世界治疗:疗效和预测生存期的替代终点

Mohr, Peter; Scherrer, Emilie; Assaf, Chalid; Bender, Marc; Berking, Carola; Chandwani, Sheenu; Eigentler, Thomas; Grimmelmann, Imke; Gutzmer, Ralf; Haferkamp, Sebastian; Hassel, Jessica C; Hauschild, Axel; Herbst, Rudolf; Jiang, Ruixuan; Kähler, Katharina C; Krepler, Clemens; Kreuter, Alexander; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Pföhler, Claudia; Rudolph, Anja; Schadendorf, Dirk; Schiavone, Maximo; Schley, Gaston; Terheyden, Patrick; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weishaupt, Carsten; Welzel, Julia; Weichenthal, Michael

Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong

香港采用PD-L1检测结合治疗策略,以帕博利珠单抗作为转移性非小细胞肺癌一线治疗的成本效益分析

Loong, Herbert H; Wong, Carlos K H; Leung, Linda Kam Suet; Dhankhar, Praveen; Insinga, Ralph P; Chandwani, Sheenu; Hsu, Danny C; Lee, Mary Y K; Huang, Min; Pellissier, James; Rai, Akanksha; Achra, Monika; Tan, Seng Chuen

Q-TWiST Analysis to Assess Benefit-Risk of Pembrolizumab in Patients with PD-L1-Positive Advanced or Metastatic Non-small Cell Lung Cancer

采用 Q-TWiST 分析评估帕博利珠单抗治疗 PD-L1 阳性晚期或转移性非小细胞肺癌患者的获益风险

Huang, Min; Pietanza, M Catherine; Samkari, Ayman; Pellissier, James; Burke, Thomas; Chandwani, Sheenu; Kong, Fansen; Pickard, A Simon

Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189

肺癌治疗终于摆脱了双药疗法:免疫疗法和 KEYNOTE-189

Sheela, Sheenu; Kim, Edward S; Mileham, Kathryn F